Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT07645339

Efficacy and Safety of a Topical Botanical Extract Formulation for Skin Barrier Repair

This is a single-center, double-blinded, placebo-controlled, prospective clinical study designed to evaluate the skin barrier repair efficacy and local tolerance of topical cosmetic formulations containing a botanical extract. Skin barrier challenge is induced via standardized tape stripping on the volar forearm of healthy subjects. The study will evaluate and compare the repair kinetics of two concentrations of the active formulation, a vehicle, and an untreated control zone over a 14-day application period.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Conditions

Age range

35 year–60 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

L'OREAL

Shanghai, China

About this study

Healthy female subjects will undergo a standardized skin barrier challenge (tape-stripping) on designated zones of their volar forearms at baseline. Formulations containing different concentrations of a botanical extract (Active Formulation A and Active Formulation B), a vehicle control, and an untreated control will be assigned to the randomized zones. Products will be applied topically twice daily for 14 days. Skin barrier repair efficacy will be assessed using clinical gradings and instrumental measurements, including Trans-Epidermal Water Loss (TEWL) and skin hydration. Local tolerance will be evaluated via clinical grading. Non-invasive skin surface biomaterial collection may be performed at designated time points for skin proteomics and lipidomics analysis.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Chinese women aged 35 to 60 years in good general health.
  • Self-reported dry skin type.
  • a hydration index < 35 and a trans-epidermal water loss (TEWL) ≥ 6g.m-2.h-1 on both anterior sides of the forearms at screening.
  • Willingness to avoid excessive sun exposure and comply with all study procedures including tape stripping and biosampling.
  • Bilateral forearms clear of scars, wounds, or significant pigment spots.

Exclusion criteria

  • Current pregnancy, breastfeeding, or planning to become pregnant.
  • Current smokers or history of smoking within the last 6 months (including e-cigarettes/nicotine products).
  • History of facial cosmetic procedures (fillers, lasers, implants, Botox, etc.).
  • Active systemic or localized skin diseases (acne, eczema, psoriasis, atopic dermatitis).
  • Allergies to cosmetics, personal care products, or their ingredients.
  • Excessive UV exposure or frequent sauna/water sports usage.
  • Use of antihistamines, antibiotics, corticosteroids, or NSAIDs within the relevant washout periods.
  • Participation in any other clinical trial within the past 30 days.

Treatment and study plan

Cosmetic Topical Product A

Other

Topical skincare formulation containing Botanical Extract (Concentration A). Applied twice daily for 14 days.

Cosmetic Topical Product B

Other

Topical skincare formulation containing Botanical Extract (Concentration B). Applied twice daily for 14 days.

Vehicle

Other

Topical formulation base (identical to investigational products but without the active botanical extract). Applied twice daily for 14 days.

Primary outcomes

  1. Clinical Scoring (Erythema, Dryness, Desquamation, Roughness, Edema, PIH)

    Time frame: Baseline, Tafter (immediately after tape stripping), T3h (3 hours after 1st product application), Day 1, Day 3, Day 7, and Day 14

    Dermatological grading of erythema, dryness, roughness, edema, desquamation and post-inflammatory hyperpigmentation using standard clinical scales

  2. Hydration

    Time frame: Baseline, Tafter (right after tape stripping), Timm (immediately after 1st product application), T1h(1 hour after 1st product application), T3h(3 hours after 1st product application), Day 1, Day 3, Day 7, and Day 14

    Hydration index measured using Corneometer

  3. TEWL

    Time frame: Baseline, post-stripping (Tafter), immediately post-first application (Timm), 1 hour post-first application (T1h), 3 hours post-first application (T3h), Day 1, Day 3, Day 7, and Day 14.

    Trans-epidermal water loss using Vapometer

Secondary outcomes

  1. Skin Structural Changes

    Time frame: Baseline, Day 3, Day 7, and Day 14

    Non-invasive evaluation of epidermis and dermis thickness/density using high-frequency ultrasound

  2. Epidermal Proteomic and Lipidomic Profile

    Time frame: Baseline, Day 7

    Characterization of stratum corneum biomarkers obtained via non-invasive tape-stripping samplings.

Sponsors and collaborators

Lead sponsor

L'Oreal

Industry

Registry information

Official study title

A Single-Center, Double-Blinded, Randomized, Placebo-Controlled, Prospective Study to Evaluate the Efficacy and Safety of a Botanical Extract in Skincare Formulations for Skin Barrier Repair on Healthy Volunteers

Important dates

Study start
2025
Primary completion
2025
Study completion
2026
First posted
Jun 12, 2026
Registry last updated
Jun 16, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.